CNBC Now: BREAKING: Abbvie says it will acquire Pharmacyclics for $261.25/share in cash and equity, or approximately $21
2015-03-05 03:58:44.611 GMT
BREAKING: Abbvie says it will acquire
Pharmacyclics for $261.25/share in cash and
equity, or approximately $21 billion. $ABBV
$PCYC
CNBC Now @CNBCnow
Sent With: Twitter for iPhone
Click here to see the original
tweet on the Twitter web site.
Twitter profile information as of March 5, 2015
Description: CNBC is First in Business Worldwide. Follow @CNBCnow for breaking
news, real-time market updates, and more. • Account managed by CNBC's breaking
news desk.
Tweets: 16,741 Following: 29 Followers: 108,800 Tweeting Since:
3/25/2009 Twitter Verified
-0- Mar/05/2015 03:58 GMT
2015-03-05 03:58:44.611 GMT
BREAKING: Abbvie says it will acquire
Pharmacyclics for $261.25/share in cash and
equity, or approximately $21 billion. $ABBV
$PCYC
CNBC Now @CNBCnow
Sent With: Twitter for iPhone
Click here to see the original
tweet on the Twitter web site.
Twitter profile information as of March 5, 2015
Description: CNBC is First in Business Worldwide. Follow @CNBCnow for breaking
news, real-time market updates, and more. • Account managed by CNBC's breaking
news desk.
Tweets: 16,741 Following: 29 Followers: 108,800 Tweeting Since:
3/25/2009 Twitter Verified
-0- Mar/05/2015 03:58 GMT